Independent information. England-wide.Public data. Clear sources.

NCT06641466

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Registered research study with 7 identifiable England locations. See source dates, location-specific recruitment and the original study record.

Study facts

Conditions recorded
Menstrual Migraine
Lead sponsor
Pfizer
Study type
Interventional
Overall status
Recruiting · this can differ by location
Age range in the record
18 Years to 45 Years
Sex eligibility field
Female
Healthy volunteers accepted
No, according to the record
Phase
Phase3
Study record last updated
9 July 2026
Study team last verified status
2026-07

These fields are a starting point. Eligibility can include diagnosis, treatment history and other criteria shown only in the complete source record. A registry entry does not establish treatment effectiveness.

England study locations

A location is reproduced as named in the study record. A source map point can represent a town; it is not used here as a hospital entrance or to identify a care provider.

Location in the sourceLocal recruitment statusGeographic connection
West Walk Surgery

Bristol · BS37 4AX

RecruitingCare in South Gloucestershire

England postcode

Bioluminux

Milton Keynes · MK15 0DU

RecruitingCare in Milton Keynes

England postcode

Hull University Teaching Hospitals NHS Trust

Hull · HU3 2JZ

RecruitingCare in Kingston upon Hull

England postcode

Re:Cognition Health - London

London · W1G 8TA

RecruitingCare in Westminster

England postcode

The Walton Centre NHS Foundation Trust

Fazakerley · L9 7LJ

RecruitingCare in Liverpool

England postcode

Panthera Clinic - York

York · YO24 4LJ

RecruitingCare in York

England postcode

Panthera Biopartners - Sheffield

Sheffield · S2 5FX

RecruitingCare in Sheffield

England postcode

Questions for the research team

  • Is this exact location currently enrolling participants, and do my circumstances meet the full criteria?
  • What visits, tests, possible risks and follow-up would participation involve?
  • Are travel costs or accessibility arrangements available?
  • How would participation affect my usual care, and what happens if I withdraw?

Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).

Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.

How we selected and connected these records

Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.